Priorities on rare cancers’ policy in National Cancer Control Plans (NCCPs)

By Neuroendocrine Cancer UK

Posted 6 years ago

26/11/2020 10am

Rare Cancers – results of a study conducted within the EU Joint Action on Rare Cancers: to which degree rare cancers are addressed in national cancer control plans (15 European countries were analysed).

Read journal here

Catch up on the latest news, stories and updates

Ongoing variability in the supply of pancreatic enzyme replacement therapy (PERT) — particularly Creon® 25,000iu capsules — has left some people struggling to obtain their prescription. ...